References
- Miled N, Yan Y, Hon WC, Perisic O, Zvelebil M, Inbar Y . Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science 2007;317:239–42.
- Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, . High frequency of mutations of the PIK3CA gene in human cancers. Science 2004;304:554.
- Philip AJ, Campbell IG, Leet C, Vincan E, Rockman SP, Whitehead RH, . The phosphatidylinositol 3′-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res 2001;61:7426–9.
- Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, . The consensus coding sequences of human breast and colorectal cancers. Science 2006;314:268–74.
- Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061–8.
- Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, . An integrated genomic analysis of human glioblastoma multiforme. Science 2008;321:1807–12.
- Mizoguchi M, Nutt CL, Mohapatra G, Louis DN. Genetic alterations of phosphoinositide 3-kinase subunit genes in human glioblastomas. Brain Pathol 2004;14:372–7.
- Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW . PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 2005;24:1477–80.
- Wu G, Xing M, Mambo E, Huang X, Liu J, Guo Z, . Somatic mutation and gain of copy number of PIK3CA in human breast cancer. Breast Cancer Res 2005;7:R609–16.